Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 5Withdrawn 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tuberous Sclerosis 1Lymphangioleiomyomatosis 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × carbon-11 acetate × Clear all
NCT02379377 2026-06-02

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
110 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT05467397 2026-01-21

Feasibility of [11C]Acetate-PET in LAM and TSC

Brigham and Women's Hospital

Phase 1/2 Active not recruiting
7 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡